| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | -0.041 | 0.3 |
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | 0.067 | 0.3 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.032 | 0.3 |
| mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | 0.042 | 0.3 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.3 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | -0.081 | 0.3 |